Product Review - Safinamide in the treatment of Parkinson’s disease

This review discusses the evidence in support of the use of safinamide, its pharmacology including its mechanism of action, and efficacy and tolerability as demonstrated in pivotal clinical trials.

It also provides commentary and recommendations from Thomas Kimber, Clinical Associate Professor in the School of Medicine, Adelaide University and Consultant Neurologist, Royal Adelaide Hospital.


Please login below to download this issue (PDF)